CMS officially removes one-time restriction for Alzheimer’s PET scan coverage
By
Aaron Dorman
Oct 17, 2023
Seniors covered by Medicare will now have expanded access to Alzheimer’s diagnostic PET scans after the CMS removed one-time restrictions.
Industry advocates join coalition to support federal bill requiring use of Alzheimer’s detection tools
By
Kimberly Bonvissuto
Oct 04, 2023
A bipartisan bill requiring the use of cognitive impairment detection tools in the early detection of Alzheimer’s disease and related dementias has the support of the senior living industry.
UCSF telehealth program cuts costs and improves outcomes for seniors with dementias
By
Aaron Dorman
Sep 25, 2023
A telehealth program out of UCSF has achieved the coveted goal of cutting costs and improving patient care for seniors with dementia, researchers state.
More news for Friday, Sept. 22
By
Kimberly Bonvissuto
Sep 22, 2023
Free, at-home COVID-19 tests will be available soon … 5G improved health of older adults: study … COVID-infected adults with 4 or more underlying diseases faced higher risk of ICU stay, death … Medicare...
17 percent of patients seeing neurologist travel long distance
Sep 13, 2023
Factors associated with long-distance travel include low neurologist density, rural setting and visits for ALS and nervous system cancer.
CMS’ shift in attitude toward family caregivers could benefit senior living: expert
By
Kimberly Bonvissuto
Aug 02, 2023
A “notable” proposal related to establishing a new payment program for caregiver training is signaling a shift in attitudes toward the contributions of family caregivers that could benefit senior living...
CMS dementia care pilot program to expand care delivery options
By
Kimberly Bonvissuto
Aug 01, 2023
Assisted living residents may be part of a new Medicare dementia care model that will test an alternative payment for family caregivers while expanding care delivery options to allow people living with...
At-home, finger-prick blood test for Alzheimer’s is latest touted stab at early diagnoses
By
Kristen Fischer
Aaron Dorman
Jul 25, 2023
A research team announced they were close to being able to diagnose Alzheimer’s disease using a finger prick blood test.
Failing to cover Alzheimer’s therapies a costly proposition: researchers
By
Kimberly Bonvissuto
Jun 16, 2023
Not managing Alzheimer’s disease and related dementias is a costly proposition not just to families, but also to society, according to two recent studies.
Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.